How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
Ambulatory Surgical Centers (ASCs) Market
- By Procedure Type: Orthopedic Surgery, Ophthalmology Surgery, Gastroenterology Procedures, Pain Management Procedures, ENT Surgery, Plastic and Reconstructive Surgery
- By Ownership Type: Physician-Owned ASCs, Hospital-Owned ASCs, Joint Venture ASCs, Corporate-Owned ASCs
- By Service Model: Single-Specialty ASCs, Multi-Specialty ASCs
- By Payer Type: Private Insurance, Medicare, Medicaid, Self-Pay/Uninsured
- By Facility Size: Small (1-2 Operating Rooms), Medium (3-5 Operating Rooms), Large (6+ Operating Rooms)
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Orthopedic Surgery leads By Procedure Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 14 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 289 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.175 →
- 12 Company Profiles 14 players: SWOT & benchmarking p.183 →
Full report · locked preview
Everything inside the Ambulatory Surgical Centers (ASCs) Market report
A complete, evidence-based study - 12 chapters and 121 sections covering market size, segmentation across 5 axes, regional analysis and 14 company profiles, forecast to 2033.
Segmentation covered
Procedure Type 6
Ownership Type 4
Service Model 2
Payer Type 4
Facility Size 3
Companies profiled
UnitedHealth Group (Optum)
Surgery Partners Inc.
Envision Healthcare Corporation
Tenet Healthcare Corporation
HCA Healthcare Inc.
Surgical Care Affiliates (SCA Health)
DaVita Inc.
AmSurg Corporation
TeamHealth Holdings Inc.
RadNet Inc.
Community Health Systems Inc.
Baylor Scott & White Health
+2 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
14 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →UnitedHealth Group (Optum)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Surgery Partners Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Envision Healthcare Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Tenet Healthcare Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →HCA Healthcare Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Surgical Care Affiliates (SCA Health)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →DaVita Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →AmSurg Corporation
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →TeamHealth Holdings Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →RadNet Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Community Health Systems Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Baylor Scott & White Health
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.220 →LifePoint Health
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →Surgical Specialty Centers
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$4,172M by 2033 · 5.9% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Orthopedic Surgery43.7
- Ophthalmology Surgery9.6
- Gastroenterology Procedures12.4
- Pain Management Procedures11.7
- ENT Surgery10.5
- Plastic and Reconstructive Surgery12.1
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$871.6M → $1,396M · 6.1%
Europe$607.5M → $852.6M · 4.3%
Asia Pacific$554.6M → $782.4M · 4.4%
Latin America$343.3M → $505.0M · 4.9%
Middle East and Africa$264.1M → $378.8M · 4.6%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →5.832026
5.842027
5.872028
5.872029
5.892030
5.902031
5.902032
5.912033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- UnitedHealth Group (Optum)19.3
- Surgery Partners Inc.21.6
- Envision Healthcare Corporation9.1
- Tenet Healthcare Corporation9.5
- HCA Healthcare Inc.4.5
- Surgical Care Affiliates (SCA Health)8.0
- Others28.0
Segment contribution to growth (%)
Fig. 18 · p.39 →Procedure Type23.8%
Ownership Type20.9%
Service Model19.4%
Payer Type13.5%
Facility Size22.5%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America35.7
- Europe21.8
- Asia Pacific20.0
- Latin America12.9
- Middle East and Africa9.7
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| UnitedHealth Group (Optum) | 79 | 97 | 97 | 89 | 76 | 98 | 89 |
| Surgery Partners Inc. | 82 | 78 | 79 | 71 | 91 | 83 | 81 |
| Envision Healthcare Corporation | 71 | 67 | 85 | 81 | 77 | 69 | 75 |
| Tenet Healthcare Corporation | 68 | 63 | 81 | 77 | 69 | 79 | 73 |
| HCA Healthcare Inc. | 54 | 74 | 66 | 62 | 58 | 54 | 61 |
| Surgical Care Affiliates (SCA Health) | 69 | 60 | 48 | 65 | 66 | 57 | 61 |
| DaVita Inc. | 61 | 53 | 58 | 54 | 55 | 46 | 55 |
| AmSurg Corporation | 51 | 42 | 60 | 46 | 43 | 43 | 48 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- UnitedHealth Group (Optum)
- Surgery Partners Inc.
- Envision Healthcare Corporation
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| UnitedHealth Group (Optum) | ◐ | ✓ | ✓ | ✓ | ✓ | ✓ |
| Surgery Partners Inc. | ◐ | ✓ | ✓ | ◐ | ✓ | ◐ |
| Envision Healthcare Corporation | ✓ | ◐ | ✓ | ◐ | ✓ | ◐ |
| Tenet Healthcare Corporation | ◐ | − | ◐ | ✓ | ◐ | ◐ |
| HCA Healthcare Inc. | − | ✓ | ◐ | ◐ | − | − |
| Surgical Care Affiliates (SCA Health) | ✓ | − | − | − | ✓ | ◐ |
| DaVita Inc. | ◐ | − | − | ◐ | ◐ | − |
| AmSurg Corporation | − | − | ◐ | − | − | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1UnitedHealth Group (Optum)89
2Surgery Partners Inc.81
3Envision Healthcare Corporation75
4Tenet Healthcare Corporation73
5HCA Healthcare Inc.61
6Surgical Care Affiliates (SCA Health)61
7DaVita Inc.55
8AmSurg Corporation48
Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
UnitedHealth Group (Optum)Surgery Partners Inc.
Challenger2
Strong scale, closing on the leaders.
Envision Healthcare CorporationTenet Healthcare Corporation
Contender2
Focused players with pockets of strength.
HCA Healthcare Inc.Surgical Care Affiliates (SCA Health)
Niche2
Specialists in a single segment or region.
DaVita Inc.AmSurg Corporation
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Procedure Type in North America, then scale across Ambulatory Surgical Centers (ASCs) Market — a $469M beachhead inside a $7.43B market.
Beachhead (SOM)$469Mobtainable near-term
Serviceable (SAM)$2.69Breachable market
Primary motionPartner-led + digitalgo-to-market
Time to scale5 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion92 fit
Orthopedic Surgery
Best fit — highest urgency & budget in Procedure Type.
Economic buyer76 fit
Ophthalmology Surgery
Strong fit — clear ROI and a fast path to value.
End user64 fit
Gastroenterology Procedures
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Procedure Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Ownership Type & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Service Model
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales43%
Partner / channel28%
Digital / self-serve19%
Marketplaces9%
Positioning & messaging
§GTM 2 · p.194 →For Procedure Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Ambulatory Surgical Centers (ASCs) Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified44%
Sales qualified23%
Evaluation15%
Closed-won6%
$12.9KCAC
$61KLTV
4.8:1LTV : CAC
< 3 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Ambulatory Surgical Centers (ASCs) Market is a resilient opportunity — $3.81B by 2033, compounding at 5.8%.
TAM · 2025$2.42Btoday
TAM · 2033$3.81Bforecast
CAGR5.8%2027–2033
Cumulative$27.6Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$3.81BTotal addressable market
SAM$1.57BServiceable available market
SOM$274MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →5.8% CAGR
Demand compounds through 2033, outpacing GDP across Procedure Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Procedure Type moving from early to mainstream — durable secular demand.
Consolidation upside
14+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$3.81BLarge & growingTAM by 2033 at 5.8% CAGR
$1.57BServiceable nowreachable with today’s model
$274MBeachhead winobtainable near-term share
14+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$2.97BBear3.8% CAGR
$3.81BBase5.8% CAGR
$4.88BBull7.7% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Ownership Type optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Ambulatory Surgical Centers (ASCs) Market — a $6.79B market by 2033. Plan: grow share from 8.8% to 14.5%.
Market size · 2033$6.79Btotal addressable
Market CAGR5.2%2027–2033
Target share14.5%from 8.8% today
Revenue ambition$985Mby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 8.8% | 14.5% | Ahead |
| Revenue | $647M | $985M | Ahead |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | On track |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | Behind |
| Gross margin | 35.1% | 38.1% | On track |
| Customer retention | 86.9% | 96.5% | On track |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Procedure Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Ownership Type capability
A defensible second engine — invest in Ownership Type to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Procedure Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Ownership Type
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $128M capacity & capability investment
- Greenlight bolt-on M&A in Ownership Type
- Authorise North America expansion plan
- Fund R&D program for Procedure Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownAt risk
- Competitive share lossBehind
- Input-cost & supply riskBehind
- Regulatory / policy changeAt risk
- Execution & talentOn track
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Ambulatory Surgical Centers (ASCs) Market conversation — a $9.17B market you can size, segment and defend in minutes.
Market size · 2033$9.17Btotal opportunity
Growth7.8%CAGR to 2033
Addressable buyers1,700+accounts in scope
Typical ROI5.5×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Procedure Type
Goal Grow share in Procedure Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →5.5×return on cost, year one
< 2 mopayback period
$55K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
14+players profiled in this market
Coverage includes
UnitedHealth Group (Optum)Surgery Partners Inc.Envision Healthcare CorporationTenet Healthcare CorporationHCA Healthcare Inc.Surgical Care Affiliates (SCA Health)DaVita Inc.AmSurg Corporation+6 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Ambulatory Surgical Centers (ASCs) Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Ambulatory Surgical Centers (ASCs) Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →Ambulatory Services Market
Market size, share, segmentation and regional forecast.
$1.9B market · 2025 base year
View report-86℃ Ultra-low Temperature Freezers Market
Market size, share, segmentation and regional forecast.
$2.7B market · 2025 base year
View reportAmbulance Services Market
Market size, share, segmentation and regional forecast.
$5.3B market · 2025 base year
View report7-Dehydrocholesterol Market
Market size, share, segmentation and regional forecast.
$1.2B market · 2025 base year
View report7-Aminocephalosporanic Acid (7-ACA) Market
Market size, share, segmentation and regional forecast.
$2.7B market · 2025 base year
View report780nm Single Frequency Laser Market
Market size, share, segmentation and regional forecast.
$457M market · 2025 base year
View report780nm Laser Market
Market size, share, segmentation and regional forecast.
$1.0B market · 2025 base year
View reportAnimal Shelter Management Software Market
Market size, share, segmentation and regional forecast.
$4.0B market · 2025 base year
View reportMultichannel Inventory Control Software Market
Market size, share, segmentation and regional forecast.
$1.2B market · 2025 base year
View report75% Disinfectant Alcohol Products Market
Market size, share, segmentation and regional forecast.
$5.2B market · 2025 base year
View report75% Alcohol Wipes Market
Market size, share, segmentation and regional forecast.
$630M market · 2025 base year
View report75% Alcohol Hand Sanitizing Wipes Market
Market size, share, segmentation and regional forecast.
$4.7B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.